Pasture Holdings (SGX:UUK) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pasture Holdings FFO?

FFO (Funds from operations) only applies to REITs.

Pasture Holdings Business Description

Address 2 Corporation Road, No. 03-04/05, Corporation Place, Singapore, SGP, 618494
Pasture Holdings Ltd is engaged in the distribution, research and development, and manufacturing of pharmaceuticals and medical supplies. The Group integrates R&D and manufacturing capabilities to deliver healthcare solutions. Its principal activities include the wholesale of medicinal and pharmaceutical products, medical, professional, scientific, and precision equipment, as well as veterinary activities. The company operates through three business segments: pharmaceutical wholesale and drop-shipment, masks and medical supplies, and other services, with the majority of its revenue coming from pharmaceutical wholesale and drop-shipment. Geographically, the company operates in Canada, Japan, Hong Kong, Singapore, and other regions, with the majority of its revenue generated in Canada.